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Introduction reduce the development of IH. Also, the influence of
haemodynamic forces like flow and shear stress on
The first report of anastomotic intimal thickening after the development of IH has been investigated. High as
well as low shear stress has been indicated as a caus-transplantation of a vein into the arterial circulation
was over 90 years ago: “within a few days after the ative factor for IH. Another possible contributing factor
in the development of IH is mismatch in elastic prop-operation, the stitches placed in making the ana-
stomosis became covered with a glistening substance erties between vascular grafts and native vessels. Sev-
eral anastomotic designs with the use of anastomoticsimilar in appearance to the normal endothelium”.1
Many reports have followed, and intimal hyperplasia cuffs and patches have been used over the years to
influence the haemodynamic forces or to decrease theis now recognised as the main cause of thrombotic
complications occurring between 2 and 24 months after compliance mismatch. Although some solutions have
had promising results with respect to improved pat-a vascular intervention.2 Intimal hyperplasia causes
restenosis in approximately 30–50% of coronary and encies of peripheral bypass grafts,10 the impact of
intimal hyperplasia on all fields of vascular inter-superficial femoral angioplasties, 20% of carotid en-
darterectomies, 20–30% of femorodistal vein bypasses, ventions remains high.
10–30% of coronary vein graft bypasses and 42–50%
of the arteriovenous fistulas for haemodialysis.2–8 The
arteriovenous fistula is the lifeline for patients who
Cell Biology of Intimal Hyperplasiadepend on haemodialysis treatment. The incidence of
thrombotic occlusion of these fistulas is 0.95 per patient
Intimal hyperplasia is thought to be due to a varietyyear. Eighty per cent of these occlusions are caused
of injuries that always involve some endothelial dam-by a stenosis due to intimal hyperplasia (IH). Fur-
age.11 It is composed of about 20% of vascular smooth-thermore, another 0.27 interventions per patient year
muscle cells (VSMC) that have migrated from theare performed on stenoses to prevent occlusion.9 Thus,
media to the intima and have proliferated and de-intimal hyperplasia poses a significant impact on mor-
posited extracellular matrix, which comprises mostbidity of haemodialysis patients and in the costs for
(60–80%) of the intimal area. Other components of thetreatment.
intima are macrophages and lymphocytes. The surfaceExtensive research has been performed to gain in-
can be endothelialised or not, depending on the extentsight into the cell biology of intimal hyperplasia and
of and time passed since the initial damage.11to find targets for pharmacological intervention to
Research on the development of intimal hyperplasia
is divided into two main regions: arterial restenosis
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access, veins are exposed to different haemodynamics phenotype. This results in increased proliferation and
matrix deposition in the intima. In the adventitia,than in the venous circulation. These altered conditions
make models of femorodistal vein graft and vascular extensive surgical exposure and dissection damages
the vasa vasorum and the autonomic nerves. Thisaccess intimal hyperplasia different from the arterial
balloon injury models. However, it is generally thought leads to de-endothelialisation within 6 h after surgery,
and stimulates intimal hyperplasia.17 Possibly thisthat the sequence of events in the development of
intimal hyperplasia in vein grafts and prosthetic grafts damage might also play a role in the de-differentiation
of the VSMC.is similar to that in the balloon injury model, but the
events inducing the start of the sequence and the speed
of development might be different.11–13 Most of the
Second wave: VSMC migration from media to intimaresearch on the sequence of events that led to intimal
hyperplasia has been conducted with arterial balloon
VSMC are embedded in an extracellular matrix (ECM).denudation models.
The extracellular matrix includes the basement mem-
brane, the inner elastic lamina and the interstitial
matrix. The inner elastic lamina is produced by the
First wave: VSMC proliferation in the media EC and mainly consists of laminin, collagen type IV
and heparan sulphate proteoglycans. The interstitial
Endothelial cell (EC) damage induces thrombus for- matrix is produced by the VSMC and is composed of
mation. Within 24 h after thrombus formation, VSMC fibronectin, thrombospondin, collagen I and II, chon-
proliferation occurs. Normal endothelium produces droitin, dermatan sulphate, proteoglycans and el-
factors like prostacyclin and heparan sulphate, which astin.18 The ECM is continuously changing by altered
inhibit VSMC proliferation.11 Damaged endothelium patterns of matrix synthesis and by the actions of
produces less heparan sulphate, and heparinolytic en- matrix metalloproteases (MMPs). An intact ECM pre-
zymes released from thrombocytes further decrease vents VSMC migration. Injury induces the production
its concentration. Moreover, the production of other of tissue-type plasminogen activator (tPA) and uro-
VSMC proliferation-inhibiting factors like nitric oxide kinase-type plasminogen activator (uPA), which de-
(NO) and natriuretic peptides by the endothelium will grade the ECM and activate MMPs.18 BFGF, PDGF,
decrease when the endothelium is damaged. Basic TGFb and ALL, which increase after injury, all increase
fibroblast growth factor (bFGF), which can be released plasminogen activator. Heparan sulphate inhibits
by dying or damaged EC and VSMC, stimulates VSMC plasminogen production, but this inhibition is ab-
proliferation.14,15 Angiotensinogen and the angiotensin olished because of EC damage and decreased
receptor (ATI) expression are increased in IH lesions. heparan sulphate production. Fibroblast growth
Angiotensin II (AII) stimulates expression of PDGF- factors significantly contribute to the medial pro-
A, bFGF, TGFb, c-myc and c-fos. These are all growth- liferation of VSMC, while the presence of either endo-
stimulating factors.11 Possible other mediators for genous or exogenous PDGF promotes migration to
VSMC proliferation are catecholamines and thrombin, the intima.19,20 Several other mediators of both the
all released upon injury.16 Thus, damage of the vessel tyrosine kinase (IGF-1, TGF-b, thrombin, interleukin-1)
wall decreases production of growth-inhibiting factors and G-protein (ALL, endothelin-1, serotonin) coupled
and increases the expression of growth-stimulating membrane receptors have been shown to participate
factors, shifting the balance toward VSMC pro- in these events.21 These circumstances produce a good
liferation. environment for migration. VSMC migration from
VSMC are present in two main phenotypes. The media to intima starts 4 days after injury, and continues
differentiated contractile phenotype mainly contains up to 1 month after injury. Recent experiments suggest
a-actin and myosin and had a low proliferation rate that the adventitia might also play a role in delivering
of <0.1%. The synthetic phenotype strongly resembles intimal cells. After angioplasty, adventitial myo-
the foetal VSMC and the fibroblast, with many cell fibroblasts have been shown to proliferate and migrate
organelles and abundant rough endoplasmic re- to the intima as well.22
ticulum, no myosin and an increase in b-actin. These
synthetic cells produce four to five times more extra-
cellular matrix than the differentiated phenotype and Third wave: intimal expansion
have an increased proliferation rate of at least 10%.11
In intimal hyperplasia an increase in the synthetic The third wave of intimal expansion probably occurs as
a result of VSMC accumulation through proliferation,phenotype is found at the expense of the differentiated
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continued migration, or both, as well as relatively the development of IH was described by Watastase.13
He discerned six steps:exuberant ECM synthesis. The processes of VSMC
accumulation and volume of ECM production appear (1) early thrombosis;
to be tightly linked, with fairly constant proportions (2) phagocytosis of thrombi;
of VSMC to ECM volumes, characterising the intimal (3) appearance and proliferation of fibroblasts in the
lesions that arise after a variety of vascular injuries.23 pseudointima;
The proportional contribution of VSMC and ECM (4) appearance and extension of endothelial cells;
volume to the overall intimal volume remains constant (5) appearance of VSMC and;
except directly beneath the endothelium, where both (6) intimal hyperplasia by proliferation of fibroblasts
VSMC proliferation and the relative proportion of and production of collagen fibrils.
VSMC are higher. Not much is known about the
In contrast to healing in injured arteries, intimalcontrol of matrix production in the intima. Growth
thickening in vascular grafts seems to occur beneathfactors such as TGF-b and PDGF are also fibroplastic,
the endothelial layer.33 This observation provides sup-i.e. they stimulate ECM production by VSMC. Thus,
port for the conclusion that endothelial cells mightthe same factors that stimulate VSMC proliferation
serve as a source of growth factors.2,34,35simultaneously increase ECM production.11
However, polytetrafluoroethylene (PTFE) grafts can
induce the production of VSMC growth factors in
several ways:
Intimal Hyperplasia in Venous and Prosthetic
(1) foreign body response activates macrophagesGrafts
which excrete growth factors;
(2) uncovered PTFE activates platelets which can re-In the normal circulation a vein is subjected to low
lease growth factors;pressure, non-pulsatile flow and a shear stress of
(3) compliance mismatch at the anastomosis may leadaround 0.2 dyne/cm2. Following grafting into the ar-
to excessive stretching of the VSMC, causing theterial system, the vein is exposed to high pressure,
VSMC to proliferate;pulsatile flow and a shear stress of approximately 3–6
(4) turbulence occurs around the anastomosis, causingdynes/cm2.24 Arterialised vein grafts obtained from
endothelial cell damage and release of growthhumans in the early postoperative period (<24 h) show
factors;focal loss of endothelial cells, particularly at the peri-
(5) zones of low shear and flow separation are presentanastomotic areas, and fibrin deposition on the in-
around the anastomosis, causing platelet ad-tima.12 This results in a loss of endothelium-dependent
herence and activation which release growthrelaxation to acetylcholine and diminished contraction
factors.2,36,37to a2-adrenergic agonists and serotonin.25–28 Alterations
in shear stress influence the expression of endothelial Haemodynamic injury at the downstream ana-
stomosis due to high flow and turbulence in AV fistulasadhesins. Vein grafting is followed by a rapid de-
position of leucocytes, platelets and other blood com- might increase endothelial permeability to blood prod-
ucts, including growth factors. The combination ofponents. These can release cytokines that may
influence VSMC proliferation and migration.24 Up to injury to the vein and PDGF release in the graft may
provoke IH.4,38 Although the sequence of events in the2 months after implantation of vein grafts, an increased
platelet activation was found.29 Also, an increase in development of intimal hyperplasia in arteriovenous
fistulas has not been examined in great detail, a pros-PDGF and bFGF production was found in the area of
IH.30 thetic arteriovenous fistula can be assumed to be a
combination of implantation of a prosthetic graftSpecimens derived from occluded human venous
bypasses indicated that intimal hyperplasia occurred and implantation of a vein in the arterial circulation.
Therefore, one may suggest that the mechanisms inat the heel, toe and floor of the host artery and that it
consists of myofibroblasts, fibrocollagen with cellular the development of intimal hyperplasia in these
separate situations can be combined to a hypothesisdegeneration and proliferation.31 Uniformly, IH oc-
curred close to or at the anastomosis, where the veins of the development of intimal hyperplasia in arterio-
venous fistulas (Fig. 1). Implantation of the PTFEwere repeatedly handled by forceps. This trauma may
have caused ischaemia or breakdown of the vein wall, graft induces platelet and macrophage activation,
which release migration- and proliferation-stimu-producing a hyper-reaction of the vein to arterial
pressure.32 lating factors. Compliance mismatch and disturbed
flow are contributing factors. The efferent veinIn prosthetic grafts, the morphological sequence of
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Fig. 1. Hypothesis on the development of intimal hyperplasia in prosthetic arteriovenous fistulas (modified from Kraiss & Clowes21).
aab Stimulating factors, ··········> Inhibiting factors
is exposed to arterial pressure and flow, causing causes EC damage, inducing platelet adhesion and
activation. The release of mediators from the involvedmechanical damage and high wall tension. The
high wall tension stretches VSMC, which induces cells induces proliferation of VSMC and degradation
of ECM, promoting migration of VSMC into theproliferation. Moreover, the mechanical trauma
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intima. The VSMC can then deposit the ECM to 42–44 Closure of the AV fistula or banding of the pros-
thesis leads to a decrease in flow. This induced ancomplete the intimal hyperplastic lesion.
increase of IH.23,43,45 Distal AV fistulas also lead to a
better patency of prosthetic peripheral bypasses in
humans.46 In bilateral venous bypass grafts of the
femoral artery in dogs, one femoral artery was leftHaemodynamics and Intimal Hyperplasia
patent to induce lower flow through the venous by-
pass, and on both sides the mid-portion of the graftShear stress and flow
was covered with a restraining MarlexÒ cuff to prevent
dilatation. Low blood flow was best associated withBlood flowing through a vascular segment exerts a
the formation of intimal hyperplasia and deformationtangential directed shear stress at the luminal surface
of the vessel wall in a circumferential direction was bestof endothelial cells. Wall shear stress is the product of
associated with medial thickening.47–49 In monkeys, AVwall shear rate, i.e. the radial derivative of the velocity
fistulas were created unilaterally to increase the flownear the wall, and the local blood viscosity. Shear
through the iliac artery. In this study, no increase instress (s) can be calculated according to Poiseuille’s
IH was found, but the wall shear stress was equal onlaw:
both sides. It was concluded that wall shear stress, and
not the flow rate, might be the essential haemodynamic
s=
4gQ
pr3 factor in IH.
50 Also, Zarins et al.51 found no increase in
intimal thickness after creation of an AV fistula on
where g=viscosity, Q=volume flow and r=internal one side of the iliac artery to increase flow, although
vessel radius. tangential wall tension and tangential wall shear stress
Wall shear stress has been shown to be an important were increased. They suggested that increased flow
determinant of the release of vasoactive compounds resulted in arterial dilatation and normalisation of wall
from the endothelial cells.39,40 Several vasoactive shear stress and that artery lumen diameter might
molecules stimulate the expression of adhesion serve to regulate wall shear stress. Hofstra et al.52 found
molecules and chemokines involved in intima–media low local flow velocities to be associated with stenotic
thickening.41 Wall shear stress is related to flow and lesions in human PTFE peripheral bypasses as well as
inversely related to diameter. If a vein is positioned in human AV fistulas. Although the above studies
in the arterial circulation, the flow through the vein suggest that low flow and low shear stress induce
increases, but so does the diameter. Whether the actual intimal hyperplasia and high flow and high shear
shear stress will be increased or lowered depends on stress inhibit intimal hyperplasia, a number of other
the proportional increase of diameter and flow. Since studies claim the opposite.
diameter is in the third dimension (see the above Implantation of 1-cm segments of inferior caval vein
equation), its influence is larger and shear stress will into the abdominal aorta in Lewis rats caused the
usually be lowered. Normal vessels respond to re- intima–media area of the vein graft to increase sig-
duced shear stress due to low flow by constricting, nificantly with time. Re-implantation of the venous
and this response is an endothelial dependent process. segment into the venous circulation caused a sig-
In rigid PTFE grafts where vasoconstriction cannot nificant decrease of the vein graft intima–media area
occur, low flow is correlated with increased intimal in 8 weeks.30 AV fistulas had a higher mean blood flow
thickening and may represent an attempt on the part and higher shear stress than venous bypass grafts in
of the endothelial cells to maintain shear stress within the same animals, and developed less IH.49 Also, in
the physiological range.23 The hypothesis that low flow PTFE AV loop fistulas created between the femoral
and low shear stress increase intimal hyperplasia has artery and the femoral vein of dogs, intimal–medial
been confirmed by many studies. After implantation thickness was 50% less in the banded (normal flow)
of 3-mm diameter PTFE prostheses in the abdominal than in the unbanded (high flow) side.53 In high flow
aorta or inferior caval vein in albino rabbits, IH oc- renal-artery-to-caval-vein anastomoses a significant
curred much faster in the prosthesis in the venous intimal thickening occurred 3 months after im-
position than in the arterial position, although the plantation.50 In humans, in vivo measurements of peak
morphological changes were mostly identical.13 Cre- systolic velocities, normalised for diameter (nPSV) 2
ation of an arteriovenous (AV) fistula distal from a weeks after implantation of graft AV fistulas, indicated
prosthetic bypass increases the flow through the by- that initial local nPSV values at the site of later stenoses
pass. In animal studies, these high flow bypasses were higher in the fistulas developing a stenosis than
in non-stenotic fistulas.54developed less IH than the normal flow bypasses.23,
Eur J Vasc Endovasc Surg Vol 19, April 2000
Intimal Hyperplasia and Venous Cuffs and Patches 341
In experimental models, following exposure to the High flow will induce flow disturbances at the ana-
stomosis, inducing a high gradient of wall shear stress.arterial environment, venous endothelial cells ex-
Low flow will actually produce reversed flow at theperience severe stretching and increased tangential
anastomosis, creating a negative wall shear stress. Bothstress, both of which contribute to endothelial cell
circumstances are thought to increase the developmentdamage.12,55 Moreover, it has been observed that cyclic
of intimal hyperplasia. Moreover, regions of high wallstretching of VSMC stimulates synthesis of collagen
shear stress could cause local vessel wall damage.and other matrix components.37 This results in wall
The vasoactive substances released from these regionsthickening, even after re-endothelialisation has oc-
might exert their action in regions of low wall shearcurred. How endothelial cells or VSMC transduce
stress, where a better interaction with the vessel wallshear and wall stress into a biochemical response that
is possible due to the longer residence time.controls smooth-muscle growth is still unclear. Several
mechanisms have been proposed, including ion chan-
nel with activation influenced by shear stress or stretch,
mechanical disruption of cell–cell contacts, alteration
Influence of graft geometry and complianceof focal adhesion dynamics by forces transmitted via
the cytoskeleton and changes in the surface con-
End-to-side (ETS) anastomoses develop more IH thancentrations of extracellular agonists.56 Moreover, posi-
end-to-end (ETE) anastomoses.47,63 However, an ETStive and negative shear stress responsive elements
distal anastomosis is usually necessary to maintain(SSREs) have recently been identified in the promoted
antegrade and retrograde perfusion. Lengthening ofregions of genes involved in the development of in-
the anastomosis reduces shear stress on the floor oftimal hyperplasia, such as PDGF-A and B and TGF-b.
the arterial wall, but not the flow disturbances at theThese SSRE can either upregulate or downregulate the
heel and toe. Since endothelial cells are orientated intranscription of these genes in response to changes in
the direction of the flow in a shingle-like configuration,shear stress.57
flow disturbances can lift up the endothelium, thusTo explain the contradictory hypotheses on high
exposing the subendothelium to the blood elementsand low shear stress as a cause for intimal hyperplasia, (platelets etc.). This could induce smooth-muscle cell
several simulation and flow visualisation models have migration and proliferation.38
been developed to gain more insight into the dis- Variation of graft diameter in ETS anastomoses of
tribution of flow velocities and shear stress and the venous femoropopliteal bypasses in sheep had no
occurrence of IH in vivo. Fei et al.58 created a 3-D influence on the development of IH.64 This undermines
numerical model with static flow. Within the ana- the theory of Madras et al.,65 who stated that a mismatch
stomosis the velocity profile was skewed towards the in diameter at the anastomosis causes energy dis-
floor with a stagnation point opposite the mid-portion sipation which would lead to physical stress trans-
of the graft lumen. A vortex was formed just upstream. mitted through the adjacent vascular wall. This stress
Skewed velocity profiles in end-to-end (ETS) ana- would be cyclic, synchronous with the heartbeat, in-
stomoses produced low or even reversed velocities ducing VSMC proliferation. Numerical simulation
along the wall in the proximal artery and regions of models indicate that the optimal diameter ratio for
anastomotic toe and heel, while producing elevated graft to native vessel is 1.6–2:1.66 The effect of graft
forward velocities along the distal outer wall of the diameter and geometry is demonstrated by Fillinger
artery. This coincides with flow visualisation studies in et al. in graft arteriovenous fistulas created between
an anastomotic model created from in vivo peripheral the iliac artery and femoral vein in dogs.67 With a
anastomoses.59 Using a higher Reynolds number to 4–7 mm tapered graft (4 mm diameter at the arterial
simulate high flow, high wall shear rates were found side and 7 mm diameter at the venous side), sig-
at all locations as compared to simulations with a low nificantly less IH developed at the distal anastomosis
Reynolds number. However, recent studies on flow as compared to 6 mm grafts. This was explained by
visualisation and numerical simulation models with less flow disturbance and turbulence at the distal
pulsatile flow indicate that high temporal and spatial anastomosis of the tapered graft.
wall shear stress gradients, and not the absolute wall A lot of research has been conducted on the angle
shear stress, are associated with IH.60–62 The high flow of the anastomosis. Thus far, no correlation has been
and low flow hypotheses as cause of intimal hy- found between the angle of the proximal anastomosis
perplasia do not rule each other out. It seems that and IH.68 In numerical simulation and flow visu-
there is an optimal shear stress, whether it is absolute alisation models, a lower angle (20°) of distal ana-
stomosis produced less flow disturbance and a loweror a gradient, at which no intimal hyperplasia occurs.
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range of shear stress variation than higher angles (30°, the predisposition of the venous anastomosis for IH.77
However, after comparing the initial elastic properties45° and 60°).58,66,69 In a flow visualisation model, the 45°
to the follow-up data on stenosis, a better initial (2angle was found to be superior, with lowest absolute
weeks postoperative) match was found around thenormalised shear rates and flow separation.70
venous anastomosis of AV fistulas which developedAnother factor that might influence IH is compliance
stenosis as compared with the non-stenotic fistulas.54mismatch. In a flow visualisation model based on an
Numeric simulation model studies of a distensibleAV loop graft between the femoral artery and vein of
ETS anastomosis confirmed the fact that compliancea dog, compliant and non-compliant PTFE grafts were
mismatch was not an important factor in the de-tested. Anastomotic flow patterns were directly af-
velopment of intimal hyperplasia. Only minor changesfected by the compliance of the graft conduit. In less
in overall wall shear stress patterns were observed. Itcompliant grafts, flow reversal and vortex formation
is suspected that the effects of wall distensibility arewere more pronounced than in more compliant
less pronounced than those brought about by changesgrafts.71 Comparing iliofemoral bypass grafts of greater
in arterial geometry and flow conditions.60saphenous vein (GSV) to PTFE grafts in dogs showed
It is understandable that vein graft compliance doesa larger suture line IH in PTFE than in GSV grafts,
not play an important role in the development of IHwhereas the IH at the arterial floor was comparable. It
when one considers that vein grafts are almost rigid atwas concluded that suture line IH represented vascular
arterial pressure and the compliance of the anastomotichealing. Greater prominence of IH in prosthetic grafts
region resembles that of the artery rather than that ofmay be related to compliance mismatch. Arterial floor
the vein.47IH was unrelated to graft type and developed in
regions of flow oscillations and relatively low shear
rate.59 Decreasing the compliance of venous bypass
grafts with a Dacron or Phynox72 mesh tube resulted
Anastomotic Cuffs and Patchesin an increase of IH.64,73 Applying a tight PTFE wrap
to reduce the luminal diameter and the tangential wall
In an attempt to improve the patency of peripheralshear stress reduced total cross-sectional wall area,
arterial bypasses, a number of different anastomosingsmooth-muscle cell volume and matrix deposition. A
techniques have been developed. In these techniques,loose wrap, which did not decrease the tangential wall
venous material is used in a transverse orientation to
shear stress, did not have these effects.74 However, create a gradual transition of elastic properties and to
Mehta et al. recently reported that a loose macroporous facilitate the anastomosing of two vessels of different
velour polyester external stent reduced intimal and diameter and wall structure.
medial thickening in venous bypass grafts in pigs. This
reduction was associated with a reduced expression of
PDGF and a reduced proliferation rate. Since the
stented grafts also had a greatly increased vascularity Miller cuff
of the neoadventitia that developed between the by-
pass and the stent, it was postulated that reduced The venous cuff was first described by Siegman in
intimal and medial thickening was caused by a de- 1979 to make a smooth connection between a venous
crease of hypoxic damage.75 or Dacron bypass and the thickened atherosclerotic
In humans, measurement of GSV compliance before artery and to make the anastomosis technically easier
implantation as a femorodistal bypass demonstrated (Fig. 2a).78 Miller adopted this technique and found
that a lower initial compliance increased the risk on that it also had a positive effect on graft patency,
the development of a stenosis. Moreover, GSV with which he ascribed to a better transition in elastic
pre-existent moderate-to-severe IH had lower com- properties.10,79
pliance than GSV with no-to-mild IH.76 In vivo meas- Although no controlled trial was conducted, the
urements of elastic properties, expressed as area “Miller cuff” was embraced by vascular surgeons to
increase (AI) during a cardiac cycle, have been per- improve the poor results of femorodistal PTFE by-
formed with ultrasound. It was found that a decline passes. Multiple reports on their achievements have
in AI occurred at the arterial anastomosis of PTFE AV been published, mostly with improved patency rates
fistulas, whereas an increase of AI occurred at the as compared to the literature or historic controls. The
venous anastomosis. The authors stated that since an 1-year patency rates of bypasses with a Miller cuff
increase in AI is associated with flow disturbances, vary from 47% to 83% compared to 66% without a
venous cuff.80–82 Three-year patencies vary betweenthe mismatch in elastic properties may contribute to
Eur J Vasc Endovasc Surg Vol 19, April 2000
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Fig. 2. Types of venous cuffs used to decrease anastomotic intimal hyperplasia.
29 and 38% with cuff and from 7 to 19% without with an arteriovenous fistula at the distal anastomosis
(n=76) to 62% by adding a Miller cuff (n=43). Itcuff.81,83–87 In a retrospective study an increase in 1-year
patency rates was reported from 38% in PTFE bypasses seemed that the cuff and arteriovenous fistula acted
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synergistically rather than simply additively. The single-centre. Therefore extrapolation to the general
peripheral bypass population is difficult.98arteriovenous fistula increases flow, thus decreasing
the risk on platelet adhesion, but it induces instability
of flow and the development of intimal hyperplasia.
It is supposed that the cuff compensates for these
Linton patchadverse effects.88
However, one retrospective study reported poor
Batson et al.99 described a patch technique in whichresults with the vein cuff. Brumbe et al.89 found that
the native artery is patched with a venous segment ofinfragenual bypasses with PTFE and a venous cuff
4–5 cm in length. In the proximal part of the veinhad a 1-year patency of 40%, whereas in normal ana-
patch, an incision is made to connect the graft (Fig.stomosed bypasses this was 61%. Above the knee even
2d). Femoropopliteal and femorodistal bypasses cre-greater differences were found: 66% patency without
ated with this technique had a 1-year patency of 74%and 14% with cuff. Recently a prospective randomised
and 2–4-years patency of 65%.study showed that the Miller cuff does not improve
the patency of above-knee femoropopliteal grafts, but
it does improve the patency of below-knee femoro-
popliteal and femorocrural bypasses. This was at- St Mary’s boot
tributed to the fact that the Miller cuff simplified the
anastomosing technique of a stiff prosthesis to a small- Although the Miller cuff and Taylor patch seemed
calibre crural vessel.90 Despite these controversies, the successful in preserving long-term patency in infra-
Miller cuff is now widely used by surgeons in various genual PTFE bypasses, the development went on. The
vascular reconstructions.91,92 rectangular angle that connects the Miller collar to
the recipient vessel produces considerable turbulence
when examined by duplex scanning.
The Taylor patch has a haemodynamically
Taylor patch smoother transition. However, it has a considerable
area of PTFE connected directly to the artery. If this
In the early 1980s, Taylor developed a venous patch connection and the compliance mismatch do play a
that was stitched into the distal anastomosis to prevent role, intimal hyperplasia remains likely at this site.
intimal hyperplasia and thus improve patency rates Therefore, Tyrrell and Wolfe designed a new venous
of PTFE bypasses (Fig. 2b). Since the proximal ana- collar that incorporated the advantage and eliminated
stomosis was also prone to develop intimal hyper- the disadvantages of both techniques (Fig. 2e).100
plasia, a different type of patch was developed in this Although their “how we do it” was published 5
position (Fig. 2c).93–95 In a subsequent publication on years ago, no clinical results have been reported as
the causes of failures of PTFE grafts, 19% of which yet. Based on the hypothesis that the geometric
was due to intimal hyperplasia, Taylor states that, alteration and not the interposition of venous material
“The development of a technique to insert vein patches is important in the supposed beneficial effect of the
across the anastomoses appears to eliminate the sig- cuff, Brennan et al.101 have developed a cuffed
nificance of intimal hyperplasia”.7 However, no lit- prosthesis by using balloon dilatation of the distal
erature or data were shown to support this statement. segment. Recently, a prosthesis based on this design
Five years later Taylor published very good patency became commercially available and the early results
rates of PTFE peripheral bypasses (5-year patency rate are promising.102
of 71% for femoropopliteal and 54% for infrapopliteal
grafts). These results were considerably better than
published previously by others (patency 0–49% over-
all) and historical series from Taylor’s own clinic (21 Karacagil’s modified cuff
infragenual femoropopliteal grafts had a 2-year pat-
ency of 81%, the first 45 patched bypasses of 94%).96 Karacagil, too, recognised the haemodynamically
unfavourable rectangular angle of the Miller cuffA sub-analysis of PTFE grafts to an isolated popliteal
segment showed even better results: the cumulative and made his own modification: a V-shaped patch
is sutured first to the prosthesis and then to thepatency was 84% at 1 year and 76% at 3 years, whereas
the literature reports patency rates of 48–53% at 1 year artery. In this way an oblique angle connection is
made. Also, suturing the cuff first to the graft andand 24–35% at 3 years.97 However, no randomisation
was performed and the results of the Taylor patch are then to the artery is easier than the other way
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around, as is done with Miller and Tyrrell cuffs Local haemodynamics within a Miller cuff were also
studied in an in vitro model. During most of the cardiac(Fig. 2f). Patency rates of the first 21 patients were
75% at 6 months and 69% at 12 months. All cycle a unidirectional coherent vortex developed in
the cuffed anastomosis. This vortex had a high velocityanastomoses were to the below-knee arteries.103
Again, the real advantages can only be assessed by with greater shear stress exertion on the vessel wall
than laminar flow. In view of the hypothesis that lowa prospective randomised study.
shear stress would induce intimal hyperplasia, the
increase in shear stress could explain the beneficial
Research on Anastomotic Cuffs and Patches effect of a cuff on anastomotic IH.108 In numerical
simulation models, the Taylor patch had a less dis-
In vitro experiments turbed flow and a lower wall shear stress gradient
than a standard anastomosis. This was associated with
Beard et al.104 were the first to examine the haemo- larger anastomotic surface areas, smoother curvatures
dynamics of the Miller cuff in vitro. They embedded at and near the anastomosis and smaller anastomotic
anastomotic complexes of PTFE prostheses to cadaver angles, with approximately 10° being superior.66 An-
internal mammarian arteries with or without a Miller other feature of the cuff was examined using greater
cuff into silastic foam and perfused it with whole saphenous vein specimens. Pressure-dependent
human citrated blood through a hydraulic system. changes in diameter indicated that the fresh long
Flow was measured proximal to the anastomosis. Ana- saphenous vein was anisotropic, with a mean longi-
stomoses with a Miller cuff had significantly higher tudinal strain 7.2· that of the circumference. Cutting
blood flows than standard anastomoses, especially the vein lengthwise and stitching it decreased this
when the recipient artery was smaller than 2 mm. The ratio to 1.95. The Miller cuff and Taylor patch are
investigators hypothesised that this haemodynamic likely to take maximum advantage of these mechanical
advantage was caused by the compliant vein cuff characteristics, since the long axis of the vein and
that allowed more distension of the anastomosis and arteriotomy are aligned. This may improve PTFE graft
reduced anastomotic resistance. patency.106,109 A cuff or patch at the venous anastomosis
However, Tyrrell et al.105 could not reproduce these reduces anastomotic resistance, which could increase
results. One of the possible explanations is that, in the volume flow and reduce flow disturbances. Also, due
in vitro setting as described above, there always is to the better transition of mechanical characteristics,
suture-line leakage. As the suture line of the Miller less flow disturbances are expected.
cuff is longer than that of the standard anastomosis, the
former would have more leakage. Flow measurements
proximal to the anastomosis, as carried out by Beard
et al., could have been biased by this leakage. Tyrrell Animal studies on mechanical properties and histology
et al. measured flow in the recipient artery to overcome
this problem and found no difference in flow. The In a study on the development of intimal hyperplasia
in the infrarenal aorta of rabbits, prosthetic patchesvolume flow was correlated to the diameter of the
vessel at the toe of the anastomoses with a Miller cuff induced more intimal hyperplasia than venous
patches. The largest intimal hyperplasia was inducedand a Taylor patch, but not in the direct anastomosis.
The authors concluded that the direct anastomosis has in regions of the arterial wall that were subjected to
the highest stress. According to the Law of Laplacean increased resistance to flow as compared to the
anastomosis with a Miller cuff or a Taylor patch. (wall stress=14 D·p·r) the arterial wall stress in-
creases with patch width. To limit intimal hyperplasia,To assess this, silicon casts of the anastomoses were
manufactured, and maximal and minimal diameter venous patches should be used and they should not
increase the total circumference by more than 30%.79were measured. The roundness of the anastomoses
was calculated by division of these two dimensions. In a canine model, Taylor-patched anastomoses of
prosthetic arteriovenous fistulas developed less in-As a perfect circle has the greatest cross-sectional area
for any given circumference, less roundness indicates timal hyperplasia than standard anastomoses.110
Suggs et al.111 implanted PTFE bypasses in carotida higher resistance. The median roundness was less
for direct anastomoses (81%) than for either the Miller arteries of dogs, with venous cuffs on the proximal
and distal anastomosis at one side and normal ana-cuff (92%) or patch (93.5%) anastomoses.106,107 The
direct anastomoses had a higher resistance, which may stomoses on the other side. The average diameter
1 mm distal to the graft toe was significantly smallerlead to a reduced volume flow and may cause more
flow disturbances. in non-cuffed than in cuffed grafts. The authors stated
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that inhibition of stenosis formation by the vein cuff hypercholesterolaemic New Zealand white rabbits re-
duced intimal thickness by 24%. EC function im-might be caused by inhibition of proliferation of
smooth-muscle cells due to a wider distribution of proved, but not the hypercholesterolaemia-associated
VSMC phenotype.115 The antioxidant Lazaroid de-kinetic energy (less compliance mismatch) or due to
interposition of venous endothelium which offers a creased the mean intimal-thickness increase by 41%
in New Zealand white rabbits with an external jugularhumoral protection.
The effect of the mechanical properties of the Miller vein interposition bypass in the carotid artery. How-
ever, the luminal diameter and medial thickness didcuff on the development of intimal hyperplasia was
studied in bilateral PTFE carotid artery bypasses in not alter, nor did the 3H-thymidine incorporation in
VSMC in vitro.116dogs.112 On one side the expandability of the vein cuff
was limited by making a PTFE jacket around it, on Dobrin et al.47 found a significant decrease in intimal
area in vein femorodistal bypass grafts in dogs treatedthe other side a normal Miller cuff was created. No
difference in intimal hyperplasia thickness was found. for 3 months with aspirin and dipyramidole as com-
pared to non-treated animals. However, the ACE-To assess whether the angle played a role, a Miller
cuff anastomosis was created on one side with a inhibitor Cilazapril, given to baboons with aortoiliac
bypasses, did not decrease IH at the site of graftvein and on the other side with PTFE. Bilateral graft
thrombosis occurred in 80% of the animals, suggesting anastomosis.117 In a sheep model, low molecular weight
heparin reduced formation of IH on a Dacron graftthat the perpendicular anastomotic angle was not pro-
tective. From these results the authors concluded that inserted in the common carotid artery.118
In humans, a reduction of the incidence of restenosisthe protective effect of the vein cuff was not mechanical
in origin. Possibly the autogenous endothelium pro- following PTCA in vivo has been achieved with an
antibody to GPIIb-IIIa, an adhesion molecule, neces-vided a humoral protective effect. This might also
explain the effectiveness of the Taylor patch, since, in sary for platelet aggregation.119 However, anti-
thrombotic approaches in humans using drugs likethe Taylor patch, part of the prosthesis is directly
connected to the native artery.112 This part would not aspirin, dipyridamole, ticlopidine, dextran, and cou-
marin have produced little or no benefit.2benefit from a mechanical effect of the vein patch.
However, if the venous endothelium releases sub-
stances that decrease IH, the whole anastomotic area
might profit.
Treatment of Stenosis Due to Intimal HyperplasiaSottiurai38 performed a series of experiments to as-
sess the cause and prevention of distal anastomotic
Since neither improvement of graft geometry norintimal hyperplasia. Using a Linton patch, he found
pharmacological therapy has yet led to prevention ofthat, in the rigid standard PTFE grafts, Doppler wave-
intimal hyperplasia, treatment of stenoses and throm-forms and patency were better than with a direct
botic occlusions remains the most important means toanastomosis. In thin-walled PTFE grafts, the Doppler
maintain graft patency.waveforms and patency were adversely affected by a
Current methods of graft salvage are either surgicalcuff. Intimal hyperplasia did occur in the cuffed rigid
or endovascular. Surgical techniques include throm-PTFE anastomoses, but was less pronounced compared
bectomy and graft revision with patch angioplasty orto prostheses without a venous cuff.113
jump graft extension.120 If the stenosis is near the
anastomosis and sufficient graft length remains, a re-
anastomosis can be performed. Other short stenoses
can be treated with removal of the hyperplastic tissueRisk Factors and Pharmacological Interventions
and closure of the vessel wall with a venous or pros-
thetic patch. Lesions that are long or difficult to reachFactors associated with failure of vascular re-
constructions include patient-related factors like con- can be bypassed with a jump graft extension.
Percutaneous endovascular techniques have a num-tinued smoking of cigarettes and hyperlipidaemia, and
local factors like reconstruction of relatively small ber of advantages over surgical treatment: due to their
technical simplicity and there being no need for generalvessels with low blood flow, excessive vessel dis-
tension during preparation of the conduit (vein graft) anaesthesia, hospital stay and morbidity are reduced.
Moreover, they can be applied in patients in bador substantial injury during the reconstruction.2,33,114
In animal studies, pharmacological interventions physical condition, in whom surgery is contra-
indicated.had variable success in diminshing the development
of IH. Dietary supplementation with L-arginine in However, the use of PTA is limited to stenoses
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shorter than 5 cm. Occlusions can be treated pharmaco- and 15° and at the toe a gradual transition in curvature
mechanically or mechanically by atherectomy,121,122 and cross-sectional area.66 However, there are no clin-
although this has less success and less long-term pat- ical data available on this design.
ency and a greater number of complications. Com- A number of different anastomosing techniques
plications include haemorrhage and pseudoaneurysm have been introduced over the last 40 years to influence
formation at the puncture site, subintimal dissection the haemodynamic conditions. All seem to have their
or performation at the angioplasty site and distal own advantages and disadvantages, with different
embolisation.123 Recurrence or recoil of the stenosis clinical results. There is a wide variability in indication
can be treated with an intravascular stent.124 for operation, site of distal anastomosis and quality of
In animal experimental studies, radiation therapy the runoff. Also there is a marked difference in re-
suppressed the development of intimal hyperplasia.125 porting the results, which were mainly retrospective
Recently, endovascular brachytherapy has been in- and sometimes reported as only primary, or also sec-
troduced clinically to reduce restonosis after PTA. The ondary patencies. A number of in vitro and animal
results are promising, although no prospective trials studies were performed trying to resolve the mystery
have been published yet.126 of cuffs and patches. Less oval distortion of the ana-
stomosis, better compliance match and interposition
of venous endothelium were mentioned as possible
positive effects. Since the actual causes of intimal
Summary hyperplasia are still unclear, these are mere spec-
ulations. Only a prospective randomised trial can re-
At present, the only approach for treatment of IH is solve the controversy that still exists as to whether the
surgery, angioplasty and possibly brachytherapy.2 different anastomotic techniques improve patency and
However, IH not only poses a mechanical ob- what technique induces the best patency results. Taylor
struction. Assuming that the vessel wall has lost its has challenged Tyrrell and Wolfe to perform a ran-
normal endothelial layer, at least transiently, and that domised trial to compare the Taylor patch to the Miller
the VSMC are transformed from a quiescent contractile cuff.95 In a letter to the editor, John Ligush convokedstate to a proliferative non-contractile phase, many
vascular surgeons to perform prospective randomisednormal physiological functions of the vessel wall are
trials on the effect of the Taylor patch, using thealso altered.127 To diminish endothelial dysfunction,
experience gained from the large carotid endart-endothelial cell injury, endothelial denudation and
erectomy trials.98smooth-muscle cell injury, the “no touch” technique
Although more authors have announced prospectiveshould be applied, where there is minimum manual
studies with different types of cuffs,88,89 only one trialand instrumental contact with the vessel.128 However,
has been published and found improved patency inthis does not influence the effects of flow, shear stress
femorocrural bypasses but not in femoropopliteal by-and compliance on the endothelium. There is still
passes.90 The Columbus Vascular Surgery Societycontroversy as to whether high or low shear stress
Taylor Patch Study is also conducting a prospectiveinduces IH. The high shear stress and low shear stress
trial. The objective is to compare 5-year patency ratestheories are probably not mutually exclusive. The
of infragenual PTFE grafts with or without Taylorstresses in the high shear regions may induce IH in
patch. Until February 1996 about one-third of the targetthe low shear regions by causing EC to secrete growth
number of patients (225) were included in 18 months.130factors that accumulate in the low flow regions.70
Results of this study are not yet published.Possibly there is an optimum for flow and/or shear
Intimal hyperplasia remains one of the majorstress with minimal development of IH, whereas an-
obstacles to long-term graft patency. It appears to beastomotic hyperplasia does occur when flow is un-
the response of the vascular smooth-muscle cells tousually slow or rapid. This hypothesis was postulated
a combination of physical, cellular and humoralin the early years of research on intimal hyperplasia
factors accompanied by dysfunctional endothelialand it seems to be still topical.129 Moreover, rather than
regulation.2,50 It is now apparent that any form ofthe absolute wall shear stress, the temporal and spatial
endothelial trauma will produce a thickened neointimagradient of wall shear stress might be of great import-
as part of the healing response. It has to be appreciatedance. Based on this hypothesis, numerical simulation
that neointimal hyperplasia occurs at different sitesmodels have calculated an optimal anastomotic design
following different procedures, but will not alwayswith minimal flow disturbance and low wall shear
have the same sequelae.127 Given the multifactorialstress gradient. The optimal anastomosis has a 1.6–2:
1 graft-to-artery diameter, a heel angle of between 10° nature of the aetiology of intimal hyperplasia, it may
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